Expertise in
13
conditions

Thomas Hermanns

Zülpicher Str. 47a, 
Koeln, NW, DE 
Clinical Trials:Currently Recruiting for 1 Trial
Expertise in
13
conditions
Zülpicher Str. 47a, 
Koeln, NW, DE 

Overview

Thomas Hermanns practices practicing medicine in Koeln, Germany.

Mr. Hermanns is highly rated in 13 conditions, according to our data. His clinical expertise encompasses Testicular Cancer, Bladder Cancer, Prostate Cancer, Lithotripsy, and Orchiectomy.

He is actively involved in clinical research, co-authoring 215 peer reviewed articles and participating in 3 clinical trials.

Gender

Male

Locations

Zülpicher Str. 47a, Koeln, NW 50674, Germany

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

International Registry for Men With Advanced Prostate Cancer (IRONMAN)
International Registry for Men With Advanced Prostate Cancer (IRONMAN)
Enrollment Status: Recruiting
Publish Date: May 22, 2026
Intervention Type: Other
Prevention of Symptomatic Skeletal Events With Denosumab Administered Every 4 Weeks Versus Every 12 Weeks - A Non-Inferiority Phase III Trial
Prevention of Symptomatic Skeletal Events With Denosumab Administered Every 4 Weeks Versus Every 12 Weeks - A Non-Inferiority Phase III Trial
Enrollment Status: Active_not_recruiting
Publish Date: December 30, 2025
Intervention Type: Drug
Study Drug: Denosumab
Study Phase: Phase 3
Investigation of Metformin in Patients With Castration Resistant Prostate Cancer in Combination With Enzalutamide vs. Enzalutamide Alone (IMPROVE TRIAL): A Randomized, Open Label, Phase II Trial
Investigation of Metformin in Patients With Castration Resistant Prostate Cancer in Combination With Enzalutamide vs. Enzalutamide Alone (IMPROVE TRIAL): A Randomized, Open Label, Phase II Trial
Enrollment Status: Terminated
Publish Date: June 27, 2023
Intervention Type: Drug
Study Drugs: Enzalutamide, Metformin
Study Phase: Phase 2
View 2 Less Clinical Trial

215 Total Publications

Patient-reported outcomes: active surveillance vs radical therapies in low-risk prostate cancer.
Patient-reported outcomes: active surveillance vs radical therapies in low-risk prostate cancer.
Journal: BJU international
Published: February 16, 2026

Frequently Asked Questions about Thomas Hermanns

Is Thomas Hermanns a top-rated expert for Testicular Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Thomas Hermanns is classified as an Distinguished expert for Testicular Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Thomas Hermanns participate in research or clinical trials?

Yes. Thomas Hermanns has published 215 articles and abstracts on conditions like Testicular Cancer. You can view a list of Thomas Hermanns's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Hermanns's expertise for a condition
ConditionClose
    View All 7 Advanced Conditions
    View All 22 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile